Manufacturing News and Research

RSS

Manufacturing is the production of products across all industries, on a large-scale, using machinery.

The Future of Vision Restoration With ReVision Implant

ReVision Implant is pioneering neuroprosthetic technology to restore vision in blind patients using advanced cortical implants and flexible electrode arrays.

26 Mar 2026

Turning Plastic Bottles into Levodopa, a Key Parkinson’s Treatment

This study demonstrates the conversion of plastic bottles into levodopa using engineered bacteria, highlighting a novel approach to sustainable drug production.

25 Mar 2026

New Mechanism Links Mitochondria Dysfunction to T Cell Exhaustion

The immune system's killer T cells do a commendable job of detecting and destroying cancer cells. But the harsh environment at the heart of tumors often saps them of their vitality, pushing them into a state of permanent lassitude called "terminal exhaustion."

23 Mar 2026

Molecular Switch Links Mitochondrial Stress to T Cell Exhaustion

Cancer-fighting T cells do not simply "run out of energy." They are molecularly reprogrammed.

19 Mar 2026

Solving a 50-year Bottleneck in Chemotherapy Drug Production

A multinational team of researchers has made a significant advance in the manufacturing of doxorubicin, a crucial chemotherapy drug.

16 Mar 2026

mAbxience Selects Genedata Bioprocess to Automate End-to-End CDMO Workflows

Genedata, a Danaher company and the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced that mAbxience has selected the Genedata Bioprocess® enterprise platform to structure and harmonize all bioprocess development data across its operations.

From Genedata AG 11 Mar 2026

Bacteria-Powered Drug Discovery: A Greener Path to Curing "Undruggable" Cancers

Researchers at the University of Bath have developed a new technology that uses bacteria to build, chemically stabilize, and test millions of potential drug molecules inside living cells, making it much quicker and easier to discover new treatments for difficult-to-treat cancers.

4 Mar 2026

Engineered E. coli Produces Key Plant Compound at Record Levels

Researchers engineered E. coli to produce orsellinic acid-derived meroterpenoids, offering a sustainable alternative to traditional plant extraction methods.

25 Feb 2026

DS Smith Engage Bees to Montor Natural Habitats at Thirteen Packaging Facilities in France

DS Smith, an International Paper company, and a leading global supplier of fiber-based and sustainable packaging solutions, announces the first results of its partnership with Apilab, a world leader in bee biomonitoring.

24 Feb 2026

Scientists Create Charge-Free Polymer to Improve Gene Therapy Delivery

Researchers from Tokyo Metropolitan University have created a new molecule which carries DNA into biological cells, to treat or vaccinate against illnesses.

23 Feb 2026

Machine Learning Enhances Manufacturing of Complex Protein Drugs

Industrial yeasts are a powerhouse of protein production, used to manufacture vaccines, biopharmaceuticals, and other useful compounds.

18 Feb 2026

Machine Learning Model Accelerates Manufacturing Timeline of Monoclonal Antibodies

As instigators of immunity, monoclonal antibodies are marvels of modern medicine, lab-made proteins that can treat cancers, autoimmune diseases, and many other conditions.

10 Feb 2026

Cellares to Expand Automated Manufacturing to Gene-Edited Stem Cell Therapies

Cellares, the first Integrated Development and Manufacturing Organization (IDMO), today announced a collaboration with the Stanford Center for Definitive and Curative Medicine (CDCM) and Stanford Innovative Medicines Accelerator (IMA) to automate manufacturing and release testing for gene-edited hematopoietic stem cell (HSC) therapies, expanding the application of Cellares' automation platforms beyond T cell therapies into a new cell modality.

From Cellares 8 Feb 2026

Expanding the Biosynthetic Capabilities of Microbes Using Light

Researchers are continually looking for new ways to hack the cellular machinery of microbes like yeast and bacteria to make products that are useful for humans and society.

2 Feb 2026

Microfluidic Technology Creates Realistic 3D Cell Environments for Research

Most cells in the human body exist in complex three-dimensional environments, yet they are still commonly studied on flat plastic dishes.

30 Jan 2026

Cellares Raises $257 Million Series D Led by BlackRock and Eclipse to Industrialize Global Cell Therapy Manufacturing with Breakthrough Automation

Cellares, the first Integrated Development and Manufacturing Organization (IDMO), today announced a $257 million Series D financing co‑led by investment funds managed by BlackRock and Eclipse, bringing the company's total capital raised to $612 million.

From Cellares 30 Jan 2026

Two-Faced Nanoparticles Restore Antibiotic Power Against Superbugs

Over the decades, many strains of disease-causing bacteria have evolved defenses to even the most potent antibiotics, setting off a growing health crisis.

14 Jan 2026

New Enzyme and Bacteria Unlock Efficient Production of Healthy Sweetener

From saccharin in the 19th century to stevia and monk fruit in the 21st, researchers and the food industry have long sought a sweetener that delivers the taste of sugar without its drawbacks-excess calories, tooth decay, and heightened risk for obesity, insulin resistance, and diabetes.

14 Jan 2026

Specialized Immune Cells Grown in Labs Offer Hope for Autoimmune Patients

Researchers at the University of British Columbia (UBC) have made a significant discovery regarding the cultivation of specialized immune cells, facilitating the development of readily available off-the-shelf cell therapies aimed at treating cancer, autoimmune diseases, and additional conditions.

9 Jan 2026

Microneedle Patches May Unlock Safer, Localized Cancer Immunotherapy

This review highlights the potential of natural polysaccharide microneedles in cancer immunotherapy, focusing on localized treatment and immune activation.

7 Jan 2026